BridgeMD
New treatment option for Anemia
Official title PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
ClinicalTrials.gov ID: NCT06542393
What this study is testing
What is Erythropoietin?
Erythropoietin is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for anemia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Anemia poses risks during coronary artery bypass grafting (CABG), increasing complications and mortality rates. Blood transfusions in cardiac surgery have negative outcomes, prompting the use of erythropoietin in Patient Blood Management (PBM) to limit transfusion needs and enhance postoperative recovery.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Eletive surgery;
- Only CABG as procedure;
- Off pump CABG candidate.
You likely can't join if
- Age \> 80 years;
- Chronic dialytic kidney disease;
- Chronic rheumatologic disease;
- Men with Hb levels \> 13 g/dl and \< 8g/dl;
- Women with Hb levels \> 12 g/dl and \< 8g/dl;
- Presence of another heart disease requiring surgical intervention;
See the full eligibility criteria
- Eletive surgery;
- Only CABG as procedure;
- Off pump CABG candidate.
- Age \> 80 years;
- Chronic dialytic kidney disease;
- Chronic rheumatologic disease;
- Men with Hb levels \> 13 g/dl and \< 8g/dl;
- Women with Hb levels \> 12 g/dl and \< 8g/dl;
- Presence of another heart disease requiring surgical intervention;
- Presence of hepatic insufficiency;
- Presence of any implantable electronic cardiac device in any cardiac chambers;
- Pregnancy;
- Diagnosis of malignant neoplasia;
- Thrombophilias;
- Need for Erythropoietin treatment due to any other disease.
- Recent ischemic event (\< 3 months).
- Ejection fraction \<30%.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.